Literature DB >> 29885264

Glucocorticoid-induced eosinopenia in humans can be linked to early transcriptional events.

P Khoury1, K Stokes1, M Gadkari2, M A Makiya1, F Legrand1, Z Hu3, A Klion1, L M Franco2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29885264      PMCID： PMC6207465          DOI： 10.1111/all.13497

Source DB:  PubMed          Journal:  Allergy        ISSN： 0105-4538            Impact factor:   13.146


× No keyword cloud information.
  10 in total

1.  Changes in circulating leukocytes induced by the administration of pituitary adrenocorticotrophic hormone in man.

Authors:  A G HILLS; P H FORSHAM; C A FINCH
Journal:  Blood       Date:  1948-07       Impact factor: 22.113

Review 2.  How I treat hypereosinophilic syndromes.

Authors:  Amy D Klion
Journal:  Blood       Date:  2015-05-11       Impact factor: 22.113

3.  Glucocorticoids preferentially upregulate functional CXCR4 expression in eosinophils.

Authors:  H Nagase; M Miyamasu; M Yamaguchi; H Kawasaki; K Ohta; K Yamamoto; Y Morita; K Hirai
Journal:  J Allergy Clin Immunol       Date:  2000-12       Impact factor: 10.793

4.  Oral corticosteroid exposure and adverse effects in asthmatic patients.

Authors:  Patrick W Sullivan; Vahram H Ghushchyan; Gary Globe; Michael Schatz
Journal:  J Allergy Clin Immunol       Date:  2017-04-27       Impact factor: 10.793

5.  Oral corticosteroids decrease eosinophil and CC chemokine expression but increase neutrophil, IL-8, and IFN-gamma-inducible protein 10 expression in asthmatic airway mucosa.

Authors:  Motonori Fukakusa; Celine Bergeron; Meri K Tulic; Pierre-Olivier Fiset; Oday Al Dewachi; Michel Laviolette; Qutayba Hamid; Jamila Chakir
Journal:  J Allergy Clin Immunol       Date:  2005-02       Impact factor: 10.793

Review 6.  Glucocorticoid-induced apoptosis in human eosinophils: mechanisms of action.

Authors:  A Druilhe; S Létuvé; M Pretolani
Journal:  Apoptosis       Date:  2003-10       Impact factor: 4.677

7.  Cortisol-induced migration of eosinophil leukocytes to lymphoid organs.

Authors:  N Sabag; M A Castrillón; A Tchernitchin
Journal:  Experientia       Date:  1978-05-15

8.  Marked and persistent eosinophilia in the absence of clinical manifestations.

Authors:  Yun-Yun K Chen; Paneez Khoury; JeanAnne M Ware; Nicole C Holland-Thomas; Jennifer L Stoddard; Shakuntala Gurprasad; Amy J Waldner; Amy D Klion
Journal:  J Allergy Clin Immunol       Date:  2013-08-26       Impact factor: 10.793

9.  The dynamics of intestinal eosinophil depletion in rats treated with dexamethasone.

Authors:  S Kawabori; K Soda; M H Perdue; J Bienenstock
Journal:  Lab Invest       Date:  1991-02       Impact factor: 5.662

10.  Quantitative investigation of human cell surface N-glycoprotein dynamics.

Authors:  Haopeng Xiao; Ronghu Wu
Journal:  Chem Sci       Date:  2016-08-15       Impact factor: 9.825
  10 in total
  8 in total

Review 1.  Therapeutic glucocorticoids: mechanisms of actions in rheumatic diseases.

Authors:  Rowan S Hardy; Karim Raza; Mark S Cooper
Journal:  Nat Rev Rheumatol       Date:  2020-02-07       Impact factor: 20.543

2.  A comparison of curated gene sets versus transcriptomics-derived gene signatures for detecting pathway activation in immune cells.

Authors:  Bin Liu; Patrick Lindner; Adan Chari Jirmo; Ulrich Maus; Thomas Illig; David S DeLuca
Journal:  BMC Bioinformatics       Date:  2020-01-28       Impact factor: 3.169

3.  Glucocorticoid-induced eosinopenia results from CXCR4-dependent bone marrow migration.

Authors:  So Gun Hong; Noriko Sato; Fanny Legrand; Manasi Gadkari; Michelle Makiya; Kindra Stokes; Katherine N Howe; Shiqin Judy Yu; Nathaniel Seth Linde; Randall R Clevenger; Timothy Hunt; Zonghui Hu; Peter L Choyke; Cynthia E Dunbar; Amy D Klion; Luis M Franco
Journal:  Blood       Date:  2020-12-03       Impact factor: 22.113

4.  Transcript- and protein-level analyses of the response of human eosinophils to glucocorticoids.

Authors:  Manasi Gadkari; Michelle A Makiya; Fanny Legrand; Kindra Stokes; Thomas Brown; Katherine Howe; Paneez Khoury; Zonghui Hu; Amy Klion; Luis M Franco
Journal:  Sci Data       Date:  2018-12-04       Impact factor: 6.444

5.  Clinical presentations and outcomes of SARS-CoV-2 infected pneumonia in pregnant women and health status of their neonates.

Authors:  Luming Xu; Qianqian Yang; Haojun Shi; Shijun Lei; Xiaoli Liu; Ying Zhu; Qiulei Wu; Xiuli Ding; Yanhong Tian; Qinghua Hu; Fenghua Chen; Zhi Geng; Xiangzhi Zeng; Lin Lin; Xuehong Cai; Min Wu; Zehua Wang; Zheng Wang; Geqing Xia; Lin Wang
Journal:  Sci Bull (Beijing)       Date:  2020-04-28       Impact factor: 11.780

Review 6.  Imaging of cell-based therapy using 89Zr-oxine ex vivo cell labeling for positron emission tomography.

Authors:  Yutaka Kurebayashi; Peter L Choyke; Noriko Sato
Journal:  Nanotheranostics       Date:  2021-01-01

7.  Pre-test probability for SARS-Cov-2-related infection score: The PARIS score.

Authors:  Mickael Tordjman; Ahmed Mekki; Rahul D Mali; Ines Saab; Guillaume Chassagnon; Enora Guillo; Robert Burns; Deborah Eshagh; Sebastien Beaune; Guillaume Madelin; Simon Bessis; Antoine Feydy; Fadila Mihoubi; Benoit Doumenc; Luc Mouthon; Robert-Yves Carlier; Jean-Luc Drapé; Marie-Pierre Revel
Journal:  PLoS One       Date:  2020-12-17       Impact factor: 3.240

8.  Use of the p-values as a size-dependent function to address practical differences when analyzing large datasets.

Authors:  Estibaliz Gómez-de-Mariscal; Vanesa Guerrero; Alexandra Sneider; Hasini Jayatilaka; Jude M Phillip; Denis Wirtz; Arrate Muñoz-Barrutia
Journal:  Sci Rep       Date:  2021-10-22       Impact factor: 4.379
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.